Zelong Cui
Overview
Explore the profile of Zelong Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui Z, Fu Y, Zhou M, Feng H, Zhang L, Ma S, et al.
Heliyon
. 2024 Aug;
10(15):e35368.
PMID: 39170430
Background: Several transcription factors and co-factors are encoded by the RFX (Regulatory Factor X) family (RFX1-8) and associated genes (RFXAP and RFXANK). Increasing evidence suggests that the RFX family and...
2.
Zhou M, Yin X, Zhang L, Cui Z, Jiang X, Ji Q, et al.
Mol Cancer Res
. 2024 Jun;
22(10):932-942.
PMID: 38847604
The blast crisis (BC) of chronic myeloid leukemia (CML) has poor efficacy against existing treatments and extremely short survival. However, the molecular mechanism of CML-chronic phase (CP) transformation to CML-BC...
3.
Yang L, Fan X, Zhou C, Wang Z, Cui Z, Wu X, et al.
Transl Lung Cancer Res
. 2023 Sep;
12(8):1766-1781.
PMID: 37691861
Background: Lung cancer has the highest prevalence and mortality of all cancers, and lung adenocarcinoma (LUAD) occupies the largest proportion of lung cancers. Herein, this study is aimed at constructing...
4.
Feng H, Fu Y, Cui Z, Zhou M, Zhang L, Gao Z, et al.
Br J Haematol
. 2023 Jul;
202(6):1178-1191.
PMID: 37469124
Although tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukaemia (CML), TKI resistance remains a major challenge. Here, we demonstrated that plant homeodomain finger protein 8 (PHF8),...
5.
Zhong G, Guo C, Shang Y, Cui Z, Zhou M, Sun M, et al.
Front Genet
. 2023 Jan;
13:1029717.
PMID: 36685973
Pyroptosis, a programmed cell death (PCD) with highly inflammatory form, has been recently found to be associated with the origin of hematopoietic malignancies. Long noncoding RNA (lncRNA) had emerged as...
6.
Yin X, Zhou M, Zhang L, Fu Y, Xu M, Wang X, et al.
Cell Death Dis
. 2022 Oct;
13(10):842.
PMID: 36184659
The blast crisis (BC) is the final deadly phase of chronic myeloid leukemia (CML), which remains a major challenge in clinical management. However, the underlying molecular mechanism driving blastic transformation...
7.
Cui Z, Fu Y, Yang Z, Gao Z, Feng H, Zhou M, et al.
Front Pharmacol
. 2022 Jun;
13:866325.
PMID: 35656299
Ferroptosis is a widespread form of programmed cell death. The environment of cancer cells makes them vulnerable to ferroptosis, including AML cells, yet the specific association between ferroptosis and AML...
8.
Zhou M, Yin X, Zheng L, Fu Y, Wang Y, Cui Z, et al.
Front Oncol
. 2021 Apr;
11:654411.
PMID: 33842368
Background: Chronic myeloid leukemia (CML) is a malignant clonal proliferative disease. Once it progresses into the phase of blast crisis (CML-BP), the curative effect is poor, and the fatality rate...
9.
Ma C, Cui Z, Wang Y, Zhang L, Wen J, Guo H, et al.
Bosn J Basic Med Sci
. 2020 Nov;
21(1):47-60.
PMID: 33188589
Pancreatic cancer (PCC) is a common malignant tumor of the digestive system that is resistant to traditional treatments and has an overall 5-year survival rate of <7%. Transcriptomics research provides...
10.
Fu Y, Xu M, Cui Z, Yang Z, Zhang Z, Yin X, et al.
EBioMedicine
. 2020 Feb;
52:102664.
PMID: 32062360
Background: Acute myeloid leukaemia (AML) is a malignant haematological tumour with high heterogeneity and mortality. A reliable prognostic assessment is critical for treatment strategies. However, the current prognostic evaluation system...